
General Cardiology
HCM management, screening, and emerging therapies
Emerging evidence with 10 primary claims
Cosegregation of hypertrophic cardiomyopathy and a fragile site on chromosome 16 in a large Italian family.
Journal of Medical Genetics — Ferraro M — Jun 1990
Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness.
Journal of Medical Genetics — Manouvrier S — Aug 1995
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies
European Heart Journal — Charron P — Jan 2018
Expression of a Mutation Causing Hypertrophic Cardiomyopathy Disrupts Sarcomere Assembly in Adult Feline Cardiac Myocytes
Circulation Research — Marian A — Jul 1995
The multiple faces of Danon disease
Hellenic Journal of Cardiology — Ntelios D — Jun 2020
Hypertrophic Cardiomyopathy With Midventricular Obstruction and Apical Aneurysm. A Case Report.
Japanese Circulation Journal-english Edition — Harada K — Jan 2001
SPECT Imaging of Apical Hypertrophic Cardiomyopathy
Clinical Nuclear Medicine — Chu W — Nov 2002
Real Time Three‐Dimensional Echocardiography Evaluation of Mitral Annular Characteristics in Patients with Myocardial Hypertrophy
Echocardiography — Yalçın F — Mar 2008
Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment
Cardiovascular Ultrasound — Losi M — Mar 2010
Specialist multidisciplinary hypertrophic cardiomyopathy clinics: should they be the standard of care?
Internal Medicine Journal — Kraus S — Mar 2015
Echocardiographic findings in pompe's disease with left ventricular obstruction
Clinical Cardiology — Shapir Y — Mar 1985
Opioid Peptide Gene Expression in the Primary Hereditary Cardiomyopathy of the Syrian Hamster
Journal of Biological Chemistry — Ventura C — Mar 1997
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
Hypertrophic cardiomyopathy (also known as HCM, HOCM, hypertrophic obstructive cardiomyopathy). HCM management, screening, and emerging therapies
As of 2026-08-29, the scientific consensus on Hypertrophic cardiomyopathy is emerging. Emerging evidence with 10 primary claims Based on 10 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/hypertrophic-cardiomyopathy.
Deterministic synthesis from Synapse's enriched corpus — 56 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Hypertrophic cardiomyopathy paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Hypertrophic cardiomyopathy papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers